These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol. Franciosa JA; Freis ED; Conway J Circulation; 1973 Jul; 48(1):118-24. PubMed ID: 4150000 [No Abstract] [Full Text] [Related]
29. Hemodynamic effects of a new antihypertensive agent, guanadrel sulfate. Cangiano JL; Bloomfield DK Curr Ther Res Clin Exp; 1969 Dec; 11(12):736-44. PubMed ID: 4984037 [No Abstract] [Full Text] [Related]
30. Hemodynamic alterations in hypertension--spontaneous changes and effects of drug therapy. A review. Lund-Johansen P Acta Med Scand Suppl; 1977; 603():1-14. PubMed ID: 325997 [No Abstract] [Full Text] [Related]
31. Haemodynamic effects of a selective adenosine A2A receptor agonist, CGS 21680, in chronic heart failure in anaesthetized rats. Nekooeian AA; Tabrizchi R Br J Pharmacol; 1998 Oct; 125(4):651-8. PubMed ID: 9831898 [TBL] [Abstract][Full Text] [Related]
32. Haemodynamic responses to rat adrenomedullin in anaesthetized spontaneously hypertensive rats. Ishiyama Y; Kitamura K; Ichiki Y; Sakata J; Kida O; Kangawa K; Eto T Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):614-8. PubMed ID: 8542672 [TBL] [Abstract][Full Text] [Related]
33. Proceedings: Comparison of some haemodynamic changes between central and intravenous administration of (plus or minus)-propranolol in anaesthetized dogs. Carter JK; Mitchell HW; Poyser RH Br J Pharmacol; 1974 May; 51(1):146P-147P. PubMed ID: 4441787 [No Abstract] [Full Text] [Related]
34. [The behavior of hemodynamic values in hypertensive patients under treatment with dichlorophenylaminoimidazoline hydrochloride]. Pozenel H Wien Klin Wochenschr; 1969 Mar; 81(10):187-92. PubMed ID: 4891025 [No Abstract] [Full Text] [Related]
35. [Effects of Tiangou Jiangya capsule on hypertension and hemodynamics in anaesthetized dogs]. Li Y; Yang Q; Weng X; Chen Y; Zhou S; Li D; Zhu X Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(23):3338-43. PubMed ID: 22393747 [TBL] [Abstract][Full Text] [Related]
36. Haemodynamic effects of tubocurarine, gallamine and suxamethonium in dogs. Hughes R Br J Anaesth; 1970 Nov; 42(11):928-34. PubMed ID: 4098970 [No Abstract] [Full Text] [Related]
37. Hemodynamic profile of a new antihypertensive agent D,L-3-[2-(3-t-butylamino-2-hydroxypropoxy)phenyl]-6-hydrazinopyridazine (SK&F 92657). Taylor EM; Cameron D; Eden RJ; Fielden R; Owen DA J Cardiovasc Pharmacol; 1981; 3(2):337-54. PubMed ID: 6166805 [TBL] [Abstract][Full Text] [Related]
38. Coronary and systemic haemodynamic effects of prostaglandins in the unanaesthetized dog. Bloor CM; White FC; Sobel BE Cardiovasc Res; 1973 Mar; 7(2):156-66. PubMed ID: 4694100 [No Abstract] [Full Text] [Related]
39. [Influence of tetrandrine on the left ventricular function and peripheral blood vessels in canines]. Zeng FD; Fang DC; Leng DM; Lü FH Yao Xue Xue Bao; 1982 Aug; 17(8):561-5. PubMed ID: 7180489 [No Abstract] [Full Text] [Related]
40. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs. Hayashi N; Yamamoto S; Kometani M; Nakao K Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]